Company Encyclopedia
View More
name
ChromaDex
CDXC.US
ChromaDex Corporation operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services.
770.89 B
CDXC.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
A
Life Sciences Tools and ServicesIndustry
Industry Ranking2/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE22.94%A
    • Profit Margin8.58%B
    • Gross Margin61.84%A
  • Growth ScoreA
    • Revenue YoY19.18%B
    • Net Profit YoY273.15%A
    • Total Assets YoY24.22%A
    • Net Assets YoY61.98%A
  • Cash ScoreB
    • Cash Flow Margin1164.88%B
    • OCF YoY19.18%B
  • Operating ScoreA
    • Turnover1.62A
  • Debt ScoreB
    • Gearing Ratio32.49%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More